Top Markets
Coin of the day
Achilles Therapeutics plc Achilles Therapeutics plc

Achilles Therapeutics plc

ACHL
Ранг среди акций #24579
Achilles Therapeutics Plc is a clinical-stage biopharmaceutical company focused... Achilles Therapeutics Plc is a clinical-stage biopharmaceutical company focused on immuno-oncology. The firm specializes in creating innovative precision T-cell therapies designed to combat a range of solid tumors. Its primary therapeutic candidates, both currently undergoing Phase I/IIa clinical trials, are CHIRON, aimed at advanced non-small cell lung cancer, and THETIS, targeting metastatic or recurrent melanoma. Beyond these, Achilles is also advancing its pipeline with treatments for head and neck squamous cell carcinoma, renal cell carcinoma, triple-negative breast cancer, and bladder cancer. Initially incorporated as Achilles TX Limited, the company officially adopted the name Achilles Therapeutics Plc in February 2021. Established in 2016, its corporate headquarters are situated in London, United Kingdom.
Цена акции
$1.48
Последняя синхронизация: 2025-03-24
Рыночная капитализация
$59.05M
Изменение (1 день)
0.00%
Изменение (1 год)
0.00%
Страна
GB
Торговля Achilles Therapeutics plc (ACHL)

Категория

История цены акций Achilles Therapeutics plc (ACHL)
Наивысшая цена закрытия: $1.42 2025-03-01

Наименьшая цена закрытия: $16.55 2021-03-01
История цены акций Achilles Therapeutics plc с 2021 по 2026
Годовая динамика цены акций
Год Результативность
2025 35.96%
2024 21.05%
2023 -23.13%
2022 -77.06%
2021 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$547.71 37.80%
US
$1.04K 57.18%
NL
$145.75 455.87%
US
$118.70 -18.24%
AU
$770.19 9.84%
CH